Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ebolavirus | 10 | 2023 | 42 | 4.700 |
Why?
|
| Hemorrhagic Fever, Ebola | 7 | 2023 | 29 | 3.670 |
Why?
|
| Ebola Vaccines | 5 | 2022 | 8 | 3.110 |
Why?
|
| Marburgvirus | 4 | 2024 | 7 | 2.170 |
Why?
|
| Antibodies, Viral | 12 | 2024 | 262 | 2.140 |
Why?
|
| Vaccines, Synthetic | 6 | 2022 | 72 | 2.070 |
Why?
|
| Viral Vaccines | 4 | 2023 | 29 | 1.970 |
Why?
|
| Vaccines, Subunit | 4 | 2022 | 30 | 1.700 |
Why?
|
| Microspheres | 3 | 2024 | 49 | 1.270 |
Why?
|
| Adjuvants, Immunologic | 5 | 2022 | 107 | 1.250 |
Why?
|
| Antibodies, Neutralizing | 5 | 2024 | 109 | 1.230 |
Why?
|
| Flavivirus | 1 | 2024 | 15 | 0.940 |
Why?
|
| Aedes | 1 | 2024 | 34 | 0.940 |
Why?
|
| Antigens, Viral | 1 | 2024 | 43 | 0.940 |
Why?
|
| Marburg Virus Disease | 1 | 2021 | 2 | 0.810 |
Why?
|
| Viral Envelope Proteins | 2 | 2024 | 82 | 0.780 |
Why?
|
| Animals | 19 | 2024 | 15081 | 0.760 |
Why?
|
| Dogs | 1 | 2019 | 149 | 0.670 |
Why?
|
| Viremia | 1 | 2018 | 42 | 0.650 |
Why?
|
| Macaca fascicularis | 3 | 2023 | 64 | 0.600 |
Why?
|
| Viral Matrix Proteins | 1 | 2017 | 17 | 0.580 |
Why?
|
| Immunization | 3 | 2022 | 92 | 0.570 |
Why?
|
| Immunoassay | 3 | 2024 | 61 | 0.560 |
Why?
|
| Viral Proteins | 1 | 2017 | 174 | 0.520 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 661 | 0.470 |
Why?
|
| Cell Line | 4 | 2024 | 1354 | 0.450 |
Why?
|
| Glycoproteins | 4 | 2022 | 106 | 0.440 |
Why?
|
| Mice | 8 | 2022 | 5913 | 0.410 |
Why?
|
| Aluminum Hydroxide | 2 | 2020 | 7 | 0.360 |
Why?
|
| Vaccination | 2 | 2022 | 288 | 0.330 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 24 | 0.330 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 70 | 0.330 |
Why?
|
| Female | 8 | 2022 | 20969 | 0.290 |
Why?
|
| Primates | 2 | 2022 | 36 | 0.270 |
Why?
|
| Water | 2 | 2023 | 296 | 0.240 |
Why?
|
| Sudan | 1 | 2023 | 2 | 0.240 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 11 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2024 | 448 | 0.230 |
Why?
|
| Democratic Republic of the Congo | 1 | 2022 | 5 | 0.220 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 142 | 0.220 |
Why?
|
| Drosophila | 1 | 2024 | 144 | 0.220 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 33 | 0.210 |
Why?
|
| Humans | 7 | 2024 | 37093 | 0.210 |
Why?
|
| Protein Subunits | 1 | 2022 | 87 | 0.210 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 237 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 290 | 0.210 |
Why?
|
| Macaca | 1 | 2022 | 38 | 0.210 |
Why?
|
| Antibody Formation | 1 | 2022 | 74 | 0.210 |
Why?
|
| Vero Cells | 2 | 2019 | 93 | 0.190 |
Why?
|
| Infant, Newborn | 1 | 2024 | 894 | 0.190 |
Why?
|
| Male | 4 | 2020 | 20025 | 0.180 |
Why?
|
| Liberia | 1 | 2019 | 13 | 0.170 |
Why?
|
| Vaccines | 1 | 2020 | 55 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2019 | 68 | 0.170 |
Why?
|
| Guinea Pigs | 1 | 2019 | 145 | 0.170 |
Why?
|
| Serologic Tests | 1 | 2019 | 43 | 0.170 |
Why?
|
| West Nile Fever | 1 | 2019 | 56 | 0.160 |
Why?
|
| Dengue | 1 | 2019 | 94 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1371 | 0.150 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 180 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2019 | 661 | 0.140 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2019 | 45 | 0.140 |
Why?
|
| Antidotes | 1 | 2012 | 3 | 0.100 |
Why?
|
| Anthrax | 1 | 2012 | 19 | 0.100 |
Why?
|
| Acetates | 1 | 2012 | 21 | 0.100 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 33 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2012 | 44 | 0.100 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2011 | 35 | 0.100 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 57 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 49 | 0.100 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 38 | 0.100 |
Why?
|
| Luteoviridae | 1 | 2010 | 1 | 0.090 |
Why?
|
| Saccharum | 1 | 2010 | 4 | 0.090 |
Why?
|
| Transformation, Genetic | 1 | 2010 | 21 | 0.090 |
Why?
|
| Freeze Drying | 2 | 2021 | 27 | 0.090 |
Why?
|
| Plants, Genetically Modified | 1 | 2010 | 46 | 0.090 |
Why?
|
| West Nile virus | 1 | 2011 | 65 | 0.090 |
Why?
|
| Dengue Virus | 1 | 2011 | 85 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2011 | 135 | 0.090 |
Why?
|
| Capsid Proteins | 1 | 2010 | 67 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2011 | 157 | 0.090 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 36 | 0.050 |
Why?
|
| Trehalose | 1 | 2022 | 4 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 69 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 4 | 0.050 |
Why?
|
| Polysorbates | 1 | 2022 | 10 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 20 | 0.050 |
Why?
|
| Emulsions | 1 | 2022 | 33 | 0.050 |
Why?
|
| Rabbits | 2 | 2012 | 283 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 65 | 0.040 |
Why?
|
| Drug Stability | 1 | 2019 | 116 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 76 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 515 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 562 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2012 | 17 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2012 | 70 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2011 | 16 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2012 | 265 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 201 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2011 | 167 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 269 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 132 | 0.020 |
Why?
|
| Aphids | 1 | 2010 | 2 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2010 | 69 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2010 | 15 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 59 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 201 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2010 | 124 | 0.020 |
Why?
|
| Plant Diseases | 1 | 2010 | 57 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 409 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 149 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 492 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 448 | 0.020 |
Why?
|
| Viral Load | 1 | 2010 | 312 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1568 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 808 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3483 | 0.010 |
Why?
|